SEC 13F Intelligence

Jarislowsky, Fraser Ltd / ABT

Jarislowsky, Fraser Ltd’s Abbott Laboratories Position

Does Jarislowsky, Fraser Ltd own Abbott Laboratories (ABT)? Yes — 2.16M shares worth $289M (+1.59% of its 13F portfolio) as of Q3 2025, down from 2.20M shares the prior filed quarter.

Position Value
$289M
Q3 2025
Shares
2.16M
% of Portfolio
+1.59%
Quarters Held
28
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $163MQ4 ’18Q1 ’19: $171MQ2 ’19: $180MQ3 ’19: $196MQ4 ’19: $206MQ4 ’19Q1 ’20: $183MQ2 ’20: $209MQ3 ’20: $249MQ4 ’20: $251MQ4 ’20Q1 ’21: $273MQ2 ’21: $266MQ3 ’21: $268MQ4 ’21: $317MQ4 ’21Q1 ’22: $279MQ2 ’22: $251MQ3 ’22: $223MQ4 ’22: $250,095Q4 ’22Q1 ’23: $228,664Q2 ’23: $239,646Q3 ’23: $211,219Q4 ’23: $233,613Q4 ’23Q1 ’24: $236,398Q2 ’24: $229MQ3 ’24: $271MQ4 ’24: $254MQ4 ’24Q1 ’25: $288MQ2 ’25: $299MQ3 ’25: $289Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20252.16M$289M+1.59%
Q2 20252.20M$299M+1.71%
Q1 20252.17M$288M+1.80%
Q4 20242.26M$254M+1.49%
Q3 20242.38M$271M+1.52%
Q2 20242.20M$229M+1.39%
Q1 20242.08M$236,398+1.36%
Q4 20232.12M$233,613+1.37%
Q3 20232.18M$211,219+1.37%
Q2 20232.20M$239,646+1.43%
Q1 20232.26M$228,664+1.41%
Q4 20222.28M$250,095+1.64%
Q3 20222.30M$223M+1.54%
Q2 20222.31M$251M+1.59%
Q1 20222.35M$279M+1.48%
Q4 20212.25M$317M+1.48%
Q3 20212.27M$268M+1.31%
Q2 20212.30M$266M+1.25%
Q1 20212.28M$273M+1.35%
Q4 20202.30M$251M+1.28%
Q3 20202.29M$249M+1.46%
Q2 20202.28M$209M+1.30%
Q1 20202.32M$183M+1.33%
Q4 20192.38M$206M+1.09%
Q3 20192.34M$196M+1.10%
Q2 20192.15M$180M+1.09%
Q1 20192.14M$171M+1.07%
Q4 20182.25M$163M+1.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jarislowsky, Fraser Ltd’s full portfolio or all institutional holders of ABT.